clorazepate dipotassium has been researched along with Anxiety Neuroses in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (84.21) | 18.7374 |
| 1990's | 2 (10.53) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (5.26) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anzola, B; Ibáñez, M; Olivares, A; Pineda, S | 1 |
| Nicholson, AN | 1 |
| Alms, DR; Benes, CO; Casten, GP; Marunycz, JD; Newton, RE | 1 |
| Gershon, S | 1 |
| Le Goc, Y; Lecrubier, Y; Widlocher, D | 1 |
| Finnerty, R; Goldberg, HL | 1 |
| Sussman, N | 1 |
| Perez, GG; Tudor, R | 1 |
| Lapierre, YD | 1 |
| Duszyk, S; Florkowski, A; Gruszczyński, W; Kocur, J; Rydzynski, Z; Trendak, W | 1 |
| Buchsbaum, MS; Hazlett, E; Sicotte, N; Stein, M; Wu, J; Zetin, M | 1 |
| Adamkiewicz, L; Duguay, R; Le Lorier, J; Messier, R; Rochefort, JG; Viguié, F | 1 |
| Bowden, CL; Cohn, JB; Fisher, JG; Rodos, JJ | 1 |
| Alderdice, MT; Marunycz, JD; Napoliello, MJ; Newton, RE | 1 |
| Zung, WW | 1 |
| Ball, R; Buchsbaum, MS; Haier, R; Hazlett, E; Katz, M; Lagunas-Solar, M; Langer, D; Sokolski, K; Wu, J | 1 |
| Fox, IL; Greenblatt, DJ; Rickels, K; Sandler, KR; Schless, A | 1 |
| Case, WG; Chung, H; Csanalosi, I; Rickels, K; Schweizer, E | 1 |
| Fabre, LF; Putman, HP | 1 |
2 review(s) available for clorazepate dipotassium and Anxiety Neuroses
| Article | Year |
|---|---|
Treating anxiety while minimizing abuse and dependence.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Clorazepate Dipotassium; Humans; Substance Withdrawal Syndrome; Substance-Related Disorders | 1993 |
Review of the side-effect profile of buspirone.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Clinical Trials as Topic; Clorazepate Dipotassium; Diazepam; Dizziness; Double-Blind Method; Drug Evaluation; Fatigue; Headache; Humans; Lorazepam; Pyrimidines | 1986 |
12 trial(s) available for clorazepate dipotassium and Anxiety Neuroses
| Article | Year |
|---|---|
The side effect profile of buspirone in comparison to active controls and placebo.
Topics: Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Clinical Trials as Topic; Clorazepate Dipotassium; Depression; Diazepam; Double-Blind Method; Headache; Humans; Nausea; Placebos; Pyrimidines; Sleep Stages | 1982 |
Drug interactions in controlled clinical trials.
Topics: Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Clinical Trials as Topic; Clorazepate Dipotassium; Diazepam; Drug Interactions; Drug Therapy, Combination; Humans; Placebos; Pyrimidines; Sleep Stages | 1982 |
Comparison of buspirone in two separate studies.
Topics: Adult; Ambulatory Care; Anxiety Disorders; Buspirone; Clinical Trials as Topic; Clorazepate Dipotassium; Depression; Diazepam; Double-Blind Method; Female; Humans; Male; Personality Inventory; Psychiatric Status Rating Scales; Pyrimidines | 1982 |
Clinical and physiological assessment of chlorazepate, diazepam and placebo in anxious neurotics.
Topics: Adolescent; Adult; Anti-Anxiety Agents; Anxiety Disorders; Arousal; Blood Pressure; Clinical Trials as Topic; Clorazepate Dipotassium; Diazepam; Female; Galvanic Skin Response; Heart Rate; Humans; Male; Middle Aged; Placebos; Psychiatric Status Rating Scales; Reaction Time; Respiration | 1975 |
Topographic EEG changes with benzodiazepine administration in generalized anxiety disorder.
Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Clorazepate Dipotassium; Electroencephalography; Female; Humans; Individuality; Male; Middle Aged | 1985 |
Double-blind comparison of buspirone and clorazepate in anxious outpatients.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Clinical Trials as Topic; Clorazepate Dipotassium; Depression; Double-Blind Method; Drug Evaluation; Female; Humans; Male; Middle Aged; Pyrimidines; Random Allocation | 1986 |
Review of the side-effect profile of buspirone.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Clinical Trials as Topic; Clorazepate Dipotassium; Diazepam; Dizziness; Double-Blind Method; Drug Evaluation; Fatigue; Headache; Humans; Lorazepam; Pyrimidines | 1986 |
Effect of clorazepate on depressed mood in anxious patients.
Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Clinical Trials as Topic; Clorazepate Dipotassium; Depression; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Personality Inventory; Placebos; Psychiatric Status Rating Scales | 1987 |
Positron emission tomography assessment of effects of benzodiazepines on regional glucose metabolic rate in patients with anxiety disorder.
Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Brain; Clorazepate Dipotassium; Deoxyglucose; Double-Blind Method; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Tomography, Emission-Computed | 1987 |
Clorazepate and lorazepam: clinical improvement and rebound anxiety.
Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Clinical Trials as Topic; Clorazepate Dipotassium; Double-Blind Method; Female; Half-Life; Humans; Lorazepam; Male; Psychiatric Status Rating Scales; Substance Withdrawal Syndrome | 1988 |
Long-term treatment of anxiety and risk of withdrawal. Prospective comparison of clorazepate and buspirone.
Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Clinical Trials as Topic; Clorazepate Dipotassium; Double-Blind Method; Drug Tolerance; Female; Humans; Male; Outcome and Process Assessment, Health Care; Panic; Patient Compliance; Patient Dropouts; Personality Inventory; Prospective Studies; Psychiatric Status Rating Scales; Substance Withdrawal Syndrome | 1988 |
Depressive symptoms and intellectual functioning in anxiety patients treated with clorazepate.
Topics: Anti-Anxiety Agents; Anxiety Disorders; Attention; Clinical Trials as Topic; Clorazepate Dipotassium; Cognition; Depression; Female; Humans; Male; Personality Inventory; Placebos; Psychiatric Status Rating Scales; Thinking | 1988 |
6 other study(ies) available for clorazepate dipotassium and Anxiety Neuroses
| Article | Year |
|---|---|
Fluoxetine combined with clorazepate dipotassium and behaviour modification for treatment of anxiety-related disorders in dogs.
Topics: Aggression; Animals; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Anxiety Disorders; Behavior Therapy; Clorazepate Dipotassium; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Fluoxetine; Male; Spain | 2014 |
[Anxiolytics in man: studies on sleep and performance (author's transl)].
Topics: Anti-Anxiety Agents; Anxiety Disorders; Arousal; Attention; Benzodiazepines; Benzodiazepinones; Clobazam; Clorazepate Dipotassium; Diazepam; Dose-Response Relationship, Drug; Humans; Motor Skills; Nordazepam; Sleep Stages; Visual Perception | 1982 |
The place of anxiety in depressive symptomatology.
Topics: Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Bipolar Disorder; Clorazepate Dipotassium; Depressive Disorder; Humans; Lorazepam; Psychiatric Status Rating Scales | 1983 |
A post-marketing surveillance survey on the use of dipotassium clorazepate in clinical practice in the Philippines.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anxiety Disorders; Child; Clorazepate Dipotassium; Drug Prescriptions; Drug Utilization; Family Practice; Female; Humans; Male; Medical Staff, Hospital; Middle Aged; Philippines; Practice Patterns, Physicians'; Product Surveillance, Postmarketing; Time Factors; Treatment Outcome | 1993 |
Clorazepat in the treatment of anxiety-depression syndroms in neuroses.
Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Clorazepate Dipotassium; Humans; Male; Middle Aged | 1989 |
[Efficacy and kinetics of chlorazepate administered to anxious patients in a single daily dose].
Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Clorazepate Dipotassium; Female; Humans; Kinetics; Male; Middle Aged; Nordazepam | 1985 |